Evaluating Treatment Tolerability in Cancer Clinical Trials Using the Toxicity Index.

J Natl Cancer Inst · 2020 · PMC7735773 · PMID 32091598

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the primary NSABP R-04 trial publication described differences in the percentage of grade 3–4 toxicities in the two-arm and four-arm trials, it did not reach statistical significance ( 12 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.